Recent Finacing
Recent Raise
Intrance Medical Systems, a Swedish subsidiary, develops and commercializes Lecigon — a fixed‑dose levodopa/carbidopa/entacapone enteral infusion for advanced Parkinson’s — marketed in Europe and pursuing U.S. clinical development.